Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+7.23%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$39.9B
AUM Growth
+$1.35B
(+3.5%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
2,910
New
490
Increased
855
Reduced
1,229
Closed
318
Top Buys
| 1 |
Tesla
TSLA
|
+$398M |
| 2 |
NVIDIA
NVDA
|
+$370M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$334M |
| 4 |
Pfizer
PFE
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$299M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$408M |
| 3 |
Snap
SNAP
|
+$379M |
| 4 |
Analog Devices
ADI
|
+$283M |
| 5 |
AT&T
T
|
+$279M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 22.87% |
| 3 | Industrials | 9.09% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Pembina Pipeline
PBA
$22.5B
| $922K | ﹤0.01% |
30,383
-305,700
| -91% | -$9.28M |
|
|
OCFT
1602
OneConnect Financial Technology
OCFT
$281M
| $921K | ﹤0.01% |
37,270
+31,580
| +555% | +$780K |
|
|
TCON
1603
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $920K | ﹤0.01% |
16,600
-1,790
| -10% | -$99.2K |
|
|
CHX
1604
DELISTED
ChampionX
CHX
| $919K | ﹤0.01% |
45,480
-44,135
| -49% | -$892K |
|
1605
UFP Technologies
UFPT
$1.55B
| $909K | ﹤0.01% |
12,936
-3,900
| -23% | -$274K |
|
1606
Business First Bancshares
BFST
$729M
| $909K | ﹤0.01% |
32,100
+1,600
| +5% | +$45.3K |
|
1607
Akebia Therapeutics
AKBA
$793M
| $905K | ﹤0.01% |
400,649
+37,757
| +10% | +$85.3K |
|
1608
PROS Holdings
PRO
$727M
| $904K | ﹤0.01% |
26,200
-93,084
| -78% | -$3.21M |
|
1609
NorthWestern Energy
NWE
$3.47B
| $903K | ﹤0.01% |
+15,800
| New | +$903K |
|
|
NUVA
1610
DELISTED
NuVasive, Inc.
NUVA
| $903K | ﹤0.01% |
17,200
-51,900
| -75% | -$2.72M |
|
1611
Accel Entertainment
ACEL
$935M
| $902K | ﹤0.01% |
+69,300
| New | +$902K |
|
1612
BridgeBio Pharma
BBIO
$10.1B
| $900K | ﹤0.01% |
53,935
-95,315
| -64% | -$1.59M |
|
1613
Shore Bancshares
SHBI
$567M
| $899K | ﹤0.01% |
43,100
+14,900
| +53% | +$311K |
|
1614
Crescent Capital BDC
CCAP
$586M
| $898K | ﹤0.01% |
+51,000
| New | +$898K |
|
1615
89bio
ETNB
$1.26B
| $898K | ﹤0.01% |
68,700
-23,300
| -25% | -$305K |
|
1616
Cyclerion Therapeutics
CYCN
$7.57M
| $897K | ﹤0.01% |
26,070
-6,315
| -19% | -$217K |
|
1617
Columbus McKinnon
CMCO
$417M
| $895K | ﹤0.01% |
19,354
-29,300
| -60% | -$1.35M |
|
1618
Globalstar
GSAT
$3.84B
| $890K | ﹤0.01% |
51,167
+22,560
| +79% | +$392K |
|
1619
Cathay General Bancorp
CATY
$3.4B
| $886K | ﹤0.01% |
20,600
-13,400
| -39% | -$576K |
|
1620
IDT Corp
IDT
$1.62B
| $883K | ﹤0.01% |
20,000
-300
| -1% | -$13.2K |
|
|
CAMP
1621
DELISTED
CalAmp Corp.
CAMP
| $883K | ﹤0.01% |
5,439
-957
| -15% | -$155K |
|
1622
Big 5 Sporting Goods
BGFV
$32.5M
| $882K | ﹤0.01% |
46,400
-4,400
| -9% | -$83.6K |
|
1623
Iovance Biotherapeutics
IOVA
$876M
| $882K | ﹤0.01% |
+46,200
| New | +$882K |
|
|
WMC
1624
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $881K | ﹤0.01% |
41,731
-32,330
| -44% | -$683K |
|
|
MORF
1625
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $881K | ﹤0.01% |
18,600
+900
| +5% | +$42.6K |
|